Did Opening Cannabis Stores in California Increase Emergency Room Visits?

Cities that authorized recreational cannabis stores saw increases in cannabis-related ER visits and poison center calls — and the effects spilled over into neighboring cities.

Han, Bing et al.·Addiction (Abingdon·2026·Moderate EvidenceObservational·1 min read
RTHC-08314ObservationalModerate Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Moderate Evidence
Sample
Data from 482 cities in California, USA from 2010 to 2020.
Participants
Data from 482 cities in California, USA from 2010 to 2020.

What This Study Found

Analyzing cannabis-related healthcare encounters across all 482 cities in California from 2010 to 2020, researchers found that authorizing storefront recreational cannabis retailers was associated with increases in three types of healthcare encounters.

Cities that permitted recreational dispensaries saw increases in population-adjusted emergency department visits, population-adjusted inpatient discharges, and the likelihood of poison center calls related to cannabis. The spatial difference-in-differences model — which accounts for both within-city changes over time and spatial relationships between cities — revealed something additional: the effects extended beyond the cities that authorized stores.

Neighboring cities that did not authorize their own retailers also experienced increases in cannabis-related healthcare encounters, suggesting a spatial spillover effect. People from cities without dispensaries appeared to be accessing cannabis from nearby authorized retailers and returning to their home communities, where any health complications would be treated locally.

Key Numbers

482 California cities analyzed, 2010–2020 study period. Three outcomes measured: ED visits, inpatient discharges, and poison center calls. Both within-city and cross-city (spatial spillover) effects detected for cities authorizing recreational cannabis retailers.

How They Did This

Secondary data analysis using a spatial difference-in-differences model at the city-quarter level across 482 California cities from 2010 to 2020. Three outcome measures: population-adjusted ED visits, population-adjusted inpatient discharges, and any poison center calls. Controlled for time-varying city-level policies and sociodemographic factors while accounting for spatial influence across neighboring cities.

Why This Research Matters

This is one of the most methodologically sophisticated studies of how cannabis retail access affects healthcare utilization. The spatial spillover finding is particularly important for local policy debates: cities that opt out of allowing dispensaries may not be fully insulated from the health effects if neighboring cities opt in.

The Bigger Picture

This study addresses the local dimension of cannabis legalization that state-level analyses miss. While state legalization sets the framework, individual cities decide whether to allow retail stores — and this research shows that those local decisions have measurable health system consequences that extend beyond city boundaries. It connects to the broader legalization outcome literature (RTHC-00253 on college student use, RTHC-00229 on pregnancy treatment completion) by showing that retail access is a distinct policy variable with its own effects.

What This Study Doesn't Tell Us

Observational study — cannot establish that dispensary authorization caused the increases (other policy or demographic changes may have occurred simultaneously). Cannabis-related healthcare encounters likely undercount actual health events. The 2010–2020 timeframe captures early legalization effects; patterns may have changed as the market matured. California's local option system may not generalize to states with different regulatory approaches.

Questions This Raises

  • ?Do the healthcare increases stabilize or continue growing as cannabis markets mature?
  • ?What types of cannabis-related emergencies are driving the ER visit increases — is it primarily edible overconsumption, pediatric exposures, or something else?
  • ?Could mandatory product safety standards reduce healthcare encounters even as retail access expands?

Trust & Context

Key Stat:
Evidence Grade:
Observational study with sophisticated spatial modeling — stronger than simple before/after comparisons but still cannot fully establish causation.
Study Age:
Published in 2026 using data through 2020. California's cannabis market has continued evolving since the study period.
Original Title:
Authorization of storefront recreational cannabis retailers and cannabis-related healthcare encounters: A local-level spatial difference-in-differences analysis in California, United States.
Published In:
Addiction (Abingdon, England) (2026)Addiction is a well-respected journal focusing on research related to substance use and addiction.
Database ID:
RTHC-08314

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-08314·https://rethinkthc.com/research/RTHC-08314

APA

Han, Bing; Gunadi, Christian; Shi, Yuyan. (2026). Authorization of storefront recreational cannabis retailers and cannabis-related healthcare encounters: A local-level spatial difference-in-differences analysis in California, United States.. Addiction (Abingdon, England). https://doi.org/10.1111/add.70318

MLA

Han, Bing, et al. "Authorization of storefront recreational cannabis retailers and cannabis-related healthcare encounters: A local-level spatial difference-in-differences analysis in California, United States.." Addiction (Abingdon, 2026. https://doi.org/10.1111/add.70318

RethinkTHC

RethinkTHC Research Database. "Authorization of storefront recreational cannabis retailers ..." RTHC-08314. Retrieved from https://rethinkthc.com/research/han-2026-authorization-of-storefront-recreational

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.